Obstructive sleep apnea is an independent predictor for dyslipidemia: Data from the European Sleep Apnea Database (ESADA)

C. Gunduz (Izmir, Turkey)

Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea
Session: Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea
Session type: Oral Presentation
Number: 3208
Disease area: Sleep and breathing disorders

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Gunduz (Izmir, Turkey). Obstructive sleep apnea is an independent predictor for dyslipidemia: Data from the European Sleep Apnea Database (ESADA). 3208

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The sleepy phenotype in mild Obstructive  Sleep Apnoea (OSA) patients: from clinical characteristics to cardiometabolic risk. Data from the European Sleep Apnea Database (ESADA).
Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders
Year: 2021


Positional obstructive sleep apnea in the European Sleep Apnoea Database (ESADA) study
Source: International Congress 2018 – Treatments that can serve as an alternative to positive airway pressure (PAP)
Year: 2018

Determinants of daytime sleepiness in mild obstructive sleep apnoea syndrome. Data from the European Sleep Apnoea Database (ESADA) cohort study.
Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Year: 2018



Change in weight and central obesity by positive airway pressure treatment in obstructive sleep apnea patients: Longitudinal data from the European Sleep Apnea Database (ESADA)
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017

The effect of positive airway pressure on cholesterol in patients with sleep apnea: Data from the European Sleep Apnea Network (ESADA)
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019


Residual daytime sleepiness (RES) in CPAP-treated obstructive sleep apnea (OSA) patients in the European Sleep Apnea Database (ESADA)
Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders
Year: 2021

Obstructive Sleep Apnea (OSA) Assessment in the elderly. Preliminary results.
Source: International Congress 2018 – Respiratory epidemiology:  from infectious diseases to lung cancer
Year: 2018

Obstructive sleep apnea and cardiovascular risk markers in community individuals- Results from the sleep apnea and vascular evaluation (SAVE) study
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016


Obstructive sleep apnoea syndrome and a calculation of cardiovascular risk
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014


The European Sleep Apnoea Database (ESADA): report from 22 European sleep laboratories
Source: Eur Respir J 2011; 38: 635-642
Year: 2011



The prevalence of Obstructive Sleep Apnea (OSA) in patients recovering from COVID-19
Source: Sleep and Breathing Conference 2021
Year: 2021




Sleep apnoea management in Europe during the COVID-19 pandemic: data from the European Sleep Apnoea Database (ESADA)
Source: Eur Respir J, 55 (6) 2001323; 10.1183/13993003.01323-2020
Year: 2020



Obstructive Sleep Apnea (OSAS) in a clinical cohort of children. Atlantis Study
Source: International Congress 2017 – What is new in respiratory and sleep physiology?
Year: 2017

Asthma  and  Obstructive Sleep Apnea Syndrome (OSAS)
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018


Hyperlipidemia Prevalence and Cholesterol Control in OSA: Data from European Sleep Apnea Database (ESADA)
Source: International Congress 2019 – Challenging issues in the clinical aspects of sleep-disordered breathing
Year: 2019



Obstructive sleep apnoea is associated with the increased prothrombotic state
Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing
Year: 2014


Nocturia is an independent predictive factor of prevalent hypertension in obstructive sleep apnea patients
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014


Increased arterial standard bicarbonate is associated with hypertension in patients with obstructive sleep apnea – data from the European Sleep Apnea DatAbase (ESADA)
Source: International Congress 2019 – Insights into the pathophysiology of sleep-disordered breathing
Year: 2019



Smoking status, clinical presentation and outcomes in obstructive sleep apnoea
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014


Prevalence of obstructive sleep apnea (OSA) in patients with lung cancer. Results from the prospective SAIL study Sleep Apnea In Lung Cancer)
Source: International Congress 2018 – Lung cancer: new aspects in diagnosis and management
Year: 2018